Search Results - "Terner-Rosenthal, J" :: K.UTB vyhledávací portál

P.2.f.009 The efficacy of levomilnacipran extended-release (ER) in the treatment of patients with depression-associated fatigue symptoms

by Fava, M, Gommoll, C, Chen, C, Greenberg, W.M, Ruth, A, D'Souza, I, Terner-Rosenthal, J
Published in European neuropsychopharmacology (01.10.2014)

Get full text

Journal Article

Loading…

P.2.f.016 Clinical relevance of levomilnacipran ER treatment in major depressive disorder: improvements in functional impairment categories

by Cutler, A, Gommoll, C, Chen, C, Greenberg, W.M, Ruth, A, D'Souza, I, Terner-Rosenthal, J
Published in European neuropsychopharmacology (01.10.2014)

Get full text

Journal Article

Loading…

P.2.c.022 Levomilnacipran in the treatment of major depressive disorder: functional health and well-being efficacy results from a phase III trial

by Blum, S, Tourkodimitris, S, Ruth, A, Terner-Rosenthal, J
Published in European neuropsychopharmacology (01.10.2012)

Get full text

Journal Article

Loading…

P.2.c.020 The efficacy and safety of levomilnacipran in the treatment of major depressive disorder: results from a phase III clinical trial

by Bose, A, Chen, C, Gommoll, C, Ruth, A, Terner-Rosenthal, J
Published in European neuropsychopharmacology (01.10.2012)

Get full text

Journal Article

P.2.f.009 The efficacy of levomilnacipran extended-release (ER) in the treatment of patients with depression-associated fatigue symptoms

P.2.f.016 Clinical relevance of levomilnacipran ER treatment in major depressive disorder: improvements in functional impairment categories

P.2.c.022 Levomilnacipran in the treatment of major depressive disorder: functional health and well-being efficacy results from a phase III trial

P.2.c.020 The efficacy and safety of levomilnacipran in the treatment of major depressive disorder: results from a phase III clinical trial

Refine Results

Format

Subject Area

Topic

Language

Year of Publication

Database